导读： 经浙江省科学技术厅组织评审和论证，认定"全省智能建造与工程软件重点实验室"等137家为全省重点实验室。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 各有关单位： 为落实省委、省政府决策部署，整合力量打造科技创新平台，加强科技基础能力建设，提升基础研究和原始创新能力，支撑构建现代化产业体 系，根据《全省重点实验室管理办法》（浙科发基〔2 0 2 3〕4 0号）规定，经我厅组织评审和论证，认定" 全省智能建造与工程软件重点实验 室"等1 3 7家为全省重点实验室（以下简称"实验室"）。现将有关事项通知如下： 一、强化责任担当。重组后的实验室，要切实增强在相关创新链中"总平台、总链长"的使命感，深入推动教科人一体融合，推动科研成果转化 产业化，推进科技开放合作，提高基础研究组织化程度，强化核心能力，提升建设效能，在增强创新体系一体化能力中发挥核心作用。 二、强化服务监督。各实验室主管部门和依托单位要指导实验室运行和管理，给予持续、稳定的科研投入，在人事、财务、科研组织等方面赋 予更大自主权，协调解决建设、运行中存在的困难和问题，督促完 ...

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The report highlights the significant progress in the Protac self-immune track, particularly with Kymera's STAT6 degrader molecule KT-621, which has shown complete degradation of the STAT6 target in both blood and skin at doses of ≥50mg. This molecule has the potential to treat Th2 inflammatory diseases and has demonstrated safety and efficacy comparable or superior to Dupilumab [4][11] - The pharmaceutical and biotechnology sector saw a 1.13% increase in the first week of June 2025, outperforming the CSI 300 index by 0.25 percentage points, ranking 17th among 31 sub-industries [5][14] Summary by Relevant Sections Protac Self-Immune Track Progress - Kymera's KT-621 has achieved complete degradation of the STAT6 target, which is crucial for treating Th2 type inflammatory diseases. The early efficacy and safety data are promising, and further data from patient populations are expected in the next 6-12 months [4][11][12] Market Performance - In the first week of June 2025, the pharmaceutical sector increased by 1.13%, with the raw material drug sector showing the highest growth at 2.89%. Other sectors such as blood products and in vitro diagnostics also performed well, while other biological products experienced a slight decline [5][18][20] - The report indicates that the overall market has been on a downward trend since the beginning of 2025, but the pharmaceutical sector has managed to maintain a positive trajectory [14][22] Recommended and Benefiting Stocks - Recommended stocks in the pharmaceutical and biotechnology sectors include: Heng Rui Medicine, East China Medicine, Sanofi Pharmaceutical, and others. In the CXO category, companies like WuXi AppTec and Tigermed are highlighted. The report also lists various companies across different sub-sectors such as traditional Chinese medicine, raw materials, medical devices, and retail pharmacies [5][24]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The report highlights the significant progress in the Protac self-immune track, particularly with Kymera's STAT6 degrader molecule KT-621, which has shown complete degradation of the STAT6 target in both blood and skin at doses of ≥50mg. This molecule has the potential to treat Th2 inflammatory diseases and has demonstrated safety and efficacy comparable or superior to Dupilumab [4][11] - The pharmaceutical and biotechnology sector saw a 1.13% increase in the first week of June 2025, outperforming the CSI 300 index by 0.25 percentage points, ranking 17th among 31 sub-industries [5][14] Summary by Relevant Sections 1. Protac Self-Immune Track Progress - Kymera's KT-621 has achieved complete degradation of the STAT6 target, which is crucial for treating Th2 type inflammatory diseases. The early efficacy and safety data are promising, with further data expected in the coming 6-12 months [4][11][12] 2. Market Performance - In the first week of June 2025, the pharmaceutical sector rose by 1.13%, with the raw material drug sector showing the highest increase of 2.89%. Other sectors such as blood products and in vitro diagnostics also performed well, while other biological products saw a slight decline [5][18][20] 3. Recommended and Benefiting Stocks - Recommended stocks include major pharmaceutical and biotechnology companies such as Heng Rui Medicine, Huadong Medicine, and others across various segments including CXO, research services, traditional Chinese medicine, raw materials, medical devices, and retail pharmacies [5][24]

Group 1 - The provincial human resources and social security department has selected and published 512 postdoctoral research positions to attract outstanding young doctoral talents from home and abroad [1] - The province has rich scientific and educational resources, with 132 postdoctoral research flow stations, 138 postdoctoral research workstations, and 242 postdoctoral innovation practice bases across various disciplines and industries [1] - The published 512 postdoctoral positions include 352 positions from flow stations and 160 positions from workstations and innovation practice bases, covering fields such as software engineering, information and communication engineering, naval and ocean engineering, pharmacy, and ecology [1] Group 2 - The province has introduced policies and benefits for postdoctoral researchers, including a reward of 300,000 yuan for those with a PhD from a globally ranked top 200 university who sign a full-time contract for over three years [2] - New postdoctoral researchers entering enterprise workstations or innovation practice bases will receive a reward of 100,000 yuan, while newly established postdoctoral flow stations and workstations will receive 150,000 yuan [2] - Local governments have also announced policies regarding funding conditions, standards, living subsidies, family placement, and children's education to ensure postdoctoral researchers can focus on their research work [2]

Group 1 - The core viewpoint of the article is the joint initiative by nine government departments in China to enhance the recruitment of research assistant positions for university graduates, aiming to support high-quality employment [1] - The initiative emphasizes the coordination of technology research and development, the growth of quality enterprises, and the development of high-tech industries alongside the creation of research assistant positions [1] - Key tasks outlined include increasing the development of research assistant positions, mobilizing national high-tech zones to create such positions, and encouraging local governments to actively develop research assistant roles [1]

Core Viewpoint - The event aims to establish a high-level communication platform for deep integration between national research institutions and local industries, promoting high-quality development in Ningbo [1][2]. Group 1: Event Overview - The launch event took place on May 27 at the Ningbo Institute of Materials Technology and Engineering, organized by the Ningbo Materials Institute and supported by local government agencies [1]. - Key attendees included Wang Hua, Vice Secretary-General of the Chinese Academy of Sciences, and Xu Yan, Vice Mayor of Ningbo, who emphasized the importance of collaboration between research institutions and local enterprises [1]. Group 2: Key Presentations - Researcher Li Lin from the Ningbo Materials Institute delivered a keynote report titled "The Era Practice of National Strategic Scientific Forces," discussing the role of the Chinese Academy of Sciences in advancing high-level scientific independence and self-reliance [1]. - The report analyzed the unique models of technology transfer and transformation in developed countries and proposed a Ningbo-specific innovation development paradigm for exploring new paths of science-industry integration [1]. Group 3: Participation and Activities - The event attracted 250 representatives from 15 affiliated units of the Chinese Academy of Sciences, local government departments, universities, research institutions, and technology enterprises [2]. - Activities included the release of enterprise needs, presentation of research outcomes, signing of key projects, project negotiations, and expert visits to enterprises, aimed at furthering the deep integration of science and industry [2].

Group 1 - The conference focused on the deep integration of technological innovation and industrial innovation, aiming to explore collaborative development mechanisms among various sectors [3][10] - The establishment of the "Youth Scientist Industry-Academia-Research Innovation Alliance" is intended to enhance the efficiency of technology transfer and address systemic barriers in the commercialization of research outcomes [3][11] - Key discussions included the challenges faced by young scientists in technology transfer, including institutional obstacles and the need for a demand-driven research approach [4][6] Group 2 - Corporate representatives highlighted three core challenges in the layout of cutting-edge technologies: strategic choices in technology paths, high-end talent cultivation, and balancing R&D investment with market returns [7] - Companies called for a collaborative mechanism between academia and industry to manage technological risks and enhance innovation efficiency [7][8] - Suggestions included creating a market-oriented mechanism for technology transfer and establishing transparent policies to support the commercialization of research outcomes [9][10] Group 3 - The conference featured a strategic donation signing ceremony between Xinhua Jin and the China Science and Technology Development Foundation, marking the initiation of practical exploration in the industry-academia-research collaborative innovation mechanism [11] - Projects discussed included advancements in aerospace technology, high-end medical devices, and artificial intelligence, aiming to enhance both fundamental research breakthroughs and industrial transformation efficiency [11][12] - The foundation aims to create an open public platform for collaboration between entrepreneurs and scientists, focusing on solving development challenges rather than merely identifying them [12][13]

导读： 西安出台措施支持科研平台服务产业发展，目标到2027年投用3个以上重大科技基础设施，建成5家陕西实验室及600家以上市 级重点实验室，转化孵化企业100家，攻关关键技术1000项。 特别提示 微信公众号机制调整，请点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 为推动科技创新与产业创新深度融合，更好发挥科研平台对产业发展的服务支撑作用，西安市市政府办公厅印发《西安 市支持重大科技基础设施等科研平台服务产业发展的若干措施》（以下简称《若干措施》）。 《若干措施》所指科研平台包括重大科技基础设施、算力基础设施、国家技术创新中心、国家实验室（基地）、全国重 点实验室、"一带一路"联合实验室、陕西实验室、市级重点实验室等。 根据《若干措施》，西安将加快推进科研平台建设，探索建立多元化投入机制和新型管理机制，进一步增强平台开放共 享水平和服务产业能力，推动相关产业平稳快速发展。到2 0 2 7年，全市投用的重大科技基础设施数量达到3个以上，陕 西实验室达到5家以上，市级及以上重点实验室总数达到6 0 0家以上。依托科研平台转化孵化企业1 0 0家以上，开展关键 核心 ...

东京大学教授佐藤佳的研究室力争接纳美国科学家 "能否让我在日本开展研究？"，东京大学开始陆续接到身在美国的研究人员的咨询。特朗普 政府上台后，美国的研究人员因预算削减而陷入困境。75％的美国研究者"正在考虑离开美 国"。不过，除部分大学外，日本对接纳并不积极。中国和欧洲的态度则不同…… 美国特朗普政府上台后，美国的研究人员因预算削减而陷入困境，北海道大学等日本国内的部分大学已 开始出现试图接纳这些研究人员的动向。如果日本能够从美国迎来优秀人才，将有望提升自身的研究实 力。但与从国家层面积极接纳美国研究人员的欧洲国家等相比，日本的行动较为迟缓。 | 日本 | 东京大学的研究人员正在摸索聘用方案。 北海道大学正在考虑自主的接纳措施 | | --- | --- | | 法国 | 在政府主导下,启动了促进研究机构 接纳外国研究人员的项目 | | Fir Fir | 马克斯 · 普朗克协会将与美国的研究机构 设立联合研究中心 | | | 经济 中文网 | | 中国 | 中国企业在多个SNS上向被解雇的 美国科学家发布广告 | "能否让我在日本开展研究？"，专门研究病毒学的东京大学教授佐藤佳开始陆续接到身在美国的研究人 ...

由湖北省科技信息研究院主办的2025湖北省科技资源共享高质量发展交流培训会在武汉举行。会上发布的《湖北省科技资源开放共享年度报告 （2024）》显示，湖北省科技资源共享服务平台入网实验室达2566个，10万元以上仪器设备20066台套，总原值突破105.79亿元。 湖北是科教大省，创新资源丰富，但创新资源多集中于高校和科研院所，其中就包括大型科学仪器。企业研发需借助先进仪器，但大型科学仪 器价格高昂，对企业来说购买很不划算，甚至无力购买。近年来，我省不断加大科技资源的建设力度，补短板、创特色，探索新模式、新路 径，让"沉睡"的仪器资源高效流转。 "科技资源的共享与高效利用，是破解科技资源配置碎片化、服务效能不均衡等瓶颈问题的关键抓手，也是推动区域创新协同发展的重要路 径。"湖北省科技厅基础研究处处长张智介绍，过去一年，全省科技系统深入贯彻"资源共享、创新协同、质效双升"的工作主线，取得了显著成 效。湖北省科技资源共享服务平台不断优化升级，资源库建设稳步推进，大型仪器设备共享利用率显著提升，科技创新券政策红利持续释放， 区域创新服务能力不断增强。 "大型仪器设备开放共享在推动科研创新、吸引和培养高水平人才方面有 ...